{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:38:44Z","timestamp":1793410724002,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11679-x","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:41:29Z","timestamp":1747230089000},"page":"7013-7026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Qualitative and quantitative assessment of gadoxetic acid MRI in distinguishing atypical focal nodular hyperplasia from hepatocellular adenoma subtypes"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6499-9261","authenticated-orcid":false,"given":"Khaled Y.","family":"Elbanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korosh","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"AlMoharb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"11679_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000268404","volume":"27","author":"LM Wenniger","year":"2010","unstructured":"Wenniger LM, de B, Terpstra V, Beuers U (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 27:24\u201331. https:\/\/doi.org\/10.1159\/000268404","journal-title":"Dig Surg"},{"key":"11679_CR2","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/ajg.2014.213","volume":"109","author":"JA Marrero","year":"2014","unstructured":"Marrero JA, Ahn J, Reddy KR, American College of Gastroenterology (2014) ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 109:1328\u20131347. https:\/\/doi.org\/10.1038\/ajg.2014.213","journal-title":"Am J Gastroenterol"},{"key":"11679_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.11101742","volume":"262","author":"L Grazioli","year":"2012","unstructured":"Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520\u2013529. https:\/\/doi.org\/10.1148\/radiol.11101742","journal-title":"Radiology"},{"key":"11679_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/13651820510028954","volume":"7","author":"L Barthelmes","year":"2005","unstructured":"Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7:186\u2013196. https:\/\/doi.org\/10.1080\/13651820510028954","journal-title":"HPB (Oxford)"},{"key":"11679_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","volume":"12","author":"JHMB Stoot","year":"2010","unstructured":"Stoot JHMB, Coelen RJS, Jong MCD, Dejong CHC (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12:509\u2013522. https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00222.x","journal-title":"HPB (Oxford)"},{"key":"11679_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","volume":"65","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL) (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386\u2013398. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.001","journal-title":"J Hepatol"},{"key":"11679_CR7","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00330-014-3144-7","volume":"24","author":"C Grieser","year":"2014","unstructured":"Grieser C, Steffen IG, Kramme I-B et al (2014) Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 24:1339\u20131348. https:\/\/doi.org\/10.1007\/s00330-014-3144-7","journal-title":"Eur Radiol"},{"key":"11679_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/jmri.23701","volume":"36","author":"K Mohajer","year":"2012","unstructured":"Mohajer K, Frydrychowicz A, Robbins JB et al (2012) Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 36:686\u2013696. https:\/\/doi.org\/10.1002\/jmri.23701","journal-title":"J Magn Reson Imaging"},{"key":"11679_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2214\/ajr.11.6836","volume":"198","author":"AS Purysko","year":"2012","unstructured":"Purysko AS, Remer EM, Coppa CP et al (2012) Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 198:115\u2013123. https:\/\/doi.org\/10.2214\/ajr.11.6836","journal-title":"AJR Am J Roentgenol"},{"key":"11679_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1148\/radiol.2015142986","volume":"277","author":"MDF McInnes","year":"2015","unstructured":"McInnes MDF, Hibbert RM, In\u00e1cio JR, Schieda N (2015) Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging\u2014a systematic review. Radiology 277:413\u2013423. https:\/\/doi.org\/10.1148\/radiol.2015142986","journal-title":"Radiology"},{"key":"11679_CR11","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00330-014-3499-9","volume":"25","author":"CH Suh","year":"2015","unstructured":"Suh CH, Kim KW, Kim GY et al (2015) The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol 25:950\u2013960. https:\/\/doi.org\/10.1007\/s00330-014-3499-9","journal-title":"Eur Radiol"},{"key":"11679_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s00261-022-03766-0","volume":"48","author":"TM Alamri","year":"2023","unstructured":"Alamri TM, Cerny M, Shaikh MA et al (2023) Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis. Abdom Radiol (NY) 48:874\u2013885. https:\/\/doi.org\/10.1007\/s00261-022-03766-0","journal-title":"Abdom Radiol (NY)"},{"key":"11679_CR13","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1148\/rg.2016160037","volume":"36","author":"N Yoneda","year":"2016","unstructured":"Yoneda N, Matsui O, Kitao A et al (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010\u20132027. https:\/\/doi.org\/10.1148\/rg.2016160037","journal-title":"Radiographics"},{"key":"11679_CR14","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/jmri.26902","volume":"51","author":"M Zulfiqar","year":"2020","unstructured":"Zulfiqar M, Sirlin CB, Yoneda N et al (2020) Hepatocellular adenomas: understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach. J Magn Reson Imaging 51:1630\u20131640. https:\/\/doi.org\/10.1002\/jmri.26902","journal-title":"J Magn Reson Imaging"},{"key":"11679_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1148\/rg.2020190037","volume":"40","author":"N Fujita","year":"2020","unstructured":"Fujita N, Nishie A, Asayama Y et al (2020) Hyperintense liver masses at hepatobiliary phase gadoxetic acid-enhanced MRI: imaging appearances and clinical importance. Radiographics 40:72\u201394. https:\/\/doi.org\/10.1148\/rg.2020190037","journal-title":"Radiographics"},{"key":"11679_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1148\/radiol.2015142366","volume":"277","author":"A Ba-Ssalamah","year":"2015","unstructured":"Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104\u2013113. https:\/\/doi.org\/10.1148\/radiol.2015142366","journal-title":"Radiology"},{"key":"11679_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2214\/ajr.22.27989","volume":"220","author":"T-H Kim","year":"2023","unstructured":"Kim T-H, Woo S, Ebrahimzadeh S et al (2023) Hepatic adenoma subtypes on hepatobiliary phase of gadoxetic acid-enhanced MRI: systematic review and meta-analysis. AJR Am J Roentgenol 220:28\u201338. https:\/\/doi.org\/10.2214\/ajr.22.27989","journal-title":"AJR Am J Roentgenol"},{"key":"11679_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s13244-015-0399-8","volume":"6","author":"M Khanna","year":"2015","unstructured":"Khanna M, Ramanathan S, Fasih N et al (2015) Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging 6:347\u2013362. https:\/\/doi.org\/10.1007\/s13244-015-0399-8","journal-title":"Insights Imaging"},{"key":"11679_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/j.sult.2016.08.001","volume":"37","author":"MD Burgio","year":"2016","unstructured":"Burgio MD, Ronot M, Salvaggio G et al (2016) Imaging of hepatic focal nodular hyperplasia: pictorial review and diagnostic strategy. Semin Ultrasound CT MRI 37:511\u2013524. https:\/\/doi.org\/10.1053\/j.sult.2016.08.001","journal-title":"Semin Ultrasound CT MRI"},{"key":"11679_CR20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1148\/rg.210156","volume":"42","author":"JD LeGout","year":"2022","unstructured":"LeGout JD, Bolan CW, Bowman AW et al (2022) Focal nodular hyperplasia and focal nodular hyperplasia-like lesions. Radiographics 42:1043\u20131061. https:\/\/doi.org\/10.1148\/rg.210156","journal-title":"Radiographics"},{"key":"11679_CR21","unstructured":"Paulette B-S, Kakar S, Nault J-C (2019) WHO classification of tumours digestive system tumours, 5th edn. International Agency for Research on Cancer, Lyon, pp 221\u2013228"},{"key":"11679_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1148\/radiol.11110023","volume":"261","author":"van","year":"2011","unstructured":"van Aalten SM, Thomeer MGJ, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172\u2013181. https:\/\/doi.org\/10.1148\/radiol.11110023","journal-title":"Radiology"},{"key":"11679_CR23","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1007\/s00330-018-5438-7","volume":"28","author":"E Reizine","year":"2018","unstructured":"Reizine E, Amaddeo G, Pigneur F et al (2018) Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol 28:4243\u20134253. https:\/\/doi.org\/10.1007\/s00330-018-5438-7","journal-title":"Eur Radiol"},{"key":"11679_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00261-012-9916-0","volume":"38","author":"CS van Kessel","year":"2013","unstructured":"van Kessel CS, de Boer E, ten Kate FJ et al (2013) Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI. Abdom Imaging 38:490\u2013501. https:\/\/doi.org\/10.1007\/s00261-012-9916-0","journal-title":"Abdom Imaging"},{"key":"11679_CR25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/jmri.24897","volume":"42","author":"M Roux","year":"2015","unstructured":"Roux M, Pigneur F, Calderaro J et al (2015) Differentiation of focal nodular hyperplasia from hepatocellular adenoma: role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. J Magn Reson Imaging 42:1249\u20131258. https:\/\/doi.org\/10.1002\/jmri.24897","journal-title":"J Magn Reson Imaging"},{"key":"11679_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12880-021-00552-0","volume":"21","author":"TA Auer","year":"2021","unstructured":"Auer TA, Walter-Rittel T, Geisel D et al (2021) HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. BMC Med Imaging 21:28. https:\/\/doi.org\/10.1186\/s12880-021-00552-0","journal-title":"BMC Med Imaging"},{"key":"11679_CR27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s11547-021-01403-2","volume":"126","author":"C Bilreiro","year":"2021","unstructured":"Bilreiro C, Soler JC, Ayuso JR et al (2021) Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma. Radiol Med 126:1379\u20131387. https:\/\/doi.org\/10.1007\/s11547-021-01403-2","journal-title":"Radiol Med"},{"key":"11679_CR28","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1007\/s00330-019-06150-7","volume":"29","author":"E Reizine","year":"2019","unstructured":"Reizine E, Ronot M, Pigneur F et al (2019) Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping. Eur Radiol 29:3791\u20133801. https:\/\/doi.org\/10.1007\/s00330-019-06150-7","journal-title":"Eur Radiol"},{"key":"11679_CR29","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jmri.24281","volume":"39","author":"MG Thomeer","year":"2014","unstructured":"Thomeer MG, Willemssen FE, Biermann KK et al (2014) MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging 39:1259\u20131264. https:\/\/doi.org\/10.1002\/jmri.24281","journal-title":"J Magn Reson Imaging"},{"key":"11679_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2214\/ajr.22.28233","volume":"220","author":"JR Tse","year":"2023","unstructured":"Tse JR, Felker ER, Cao JJ et al (2023) Hepatocellular adenoma subtypes based on 2017 classification system: exploratory study of gadoxetate disodium-enhanced MRI features with proposal of a diagnostic algorithm. AJR Am J Roentgenol 220:539\u2013550. https:\/\/doi.org\/10.2214\/ajr.22.28233","journal-title":"AJR Am J Roentgenol"},{"key":"11679_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2214\/ajr.175.3.1750687","volume":"175","author":"KJ Mortel\u00e9","year":"2000","unstructured":"Mortel\u00e9 KJ, Praet M, Vlierberghe HV et al (2000) CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic\u2014pathologic correlation. AJR Am J Roentgenol 175:687\u2013692. https:\/\/doi.org\/10.2214\/ajr.175.3.1750687","journal-title":"AJR Am J Roentgenol"},{"key":"11679_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1148\/radiol.2015142449","volume":"279","author":"JR Tse","year":"2016","unstructured":"Tse JR, Naini BV, Lu DSK, Raman SS (2016) Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology 279:118\u2013127. https:\/\/doi.org\/10.1148\/radiol.2015142449","journal-title":"Radiology"},{"key":"11679_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.22417","volume":"48","author":"H Laumonier","year":"2008","unstructured":"Laumonier H, Bioulac-Sage P, Laurent C et al (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808\u2013818. https:\/\/doi.org\/10.1002\/hep.22417","journal-title":"Hepatology"},{"key":"11679_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2214\/ajr.11.7750","volume":"199","author":"M Bieze","year":"2012","unstructured":"Bieze M, van den Esschert JW, Nio CY et al (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 199:26\u201334. https:\/\/doi.org\/10.2214\/ajr.11.7750","journal-title":"AJR Am J Roentgenol"},{"key":"11679_CR35","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s00330-012-2676-y","volume":"23","author":"M Ronot","year":"2013","unstructured":"Ronot M, Paradis V, Duran R et al (2013) MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 23:914\u2013923. https:\/\/doi.org\/10.1007\/s00330-012-2676-y","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11679-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11679-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11679-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:16:16Z","timestamp":1761599776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11679-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["11679"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11679-x","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Assistant Professor, Dr Khaled Y Elbanna.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Katherine Lajkosz, MSc, Senior Biostatistician at the Princess Margaret Cancer, provided statistics consultation and contributed to in-depth data analyses.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}